Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | PPARG | P37231 | 2/20 | 0.57 |
| ▸ | PPARA | Q07869 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | CTSS | P25774 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6792877 | 0.96 | ALDH1A1 (0.58) | ALDH1A1PPARGPPARASLC6A2TDP1 | |
| SCHEMBL6792870 | 0.96 | ALDH1A1 (0.58) | ALDH1A1PPARGPPARASLC6A2TDP1 | |
| SCHEMBL9234482 | 0.91 | LMNA (0.56) | ALDH1A1PPARGPPARASLC6A2TDP1 | |
| SCHEMBL5182481 | 0.91 | LMNA (0.56) | ALDH1A1PPARGPPARASLC6A2TDP1 | |
| SCHEMBL20004309 | 0.89 | ALDH1A1 (0.50) | ALDH1A1PPARGPPARASLC6A2TDP1 | |
| SCHEMBL28968069 | 0.89 | PSEN1 (0.52) | ALDH1A1PPARGPPARASLC6A2TDP1 | |
| SCHEMBL10594163 | 0.87 | ALDH1A1 (0.49) | ALDH1A1PPARGPPARASLC6A2TDP1 | |
| SCHEMBL28703363 | 0.87 | ATM (0.61) | ALDH1A1PPARGPPARATDP1KMT2A | |
| SCHEMBL1393871 | 0.87 | PTGS1 (0.67) | PPARGPPARASLC6A2PGRADORA3 | |
| SCHEMBL31242951 | 0.86 | ALDH1A1 (0.51) | ALDH1A1PPARGPPARASLC6A2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118812412-A | Preparation method of spirotrienone and coumarin and derivatives thereof | 黄淮学院 | 2024-10-22 | — | — | CN | claimed |
| CN-118162196-A | Heterogeneous catalyst for synthesizing benzyl phenylpropionate compound | 中国石油化工股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-102417468-A | Synthetic method of lambdacyhalothrin hapten | LIBING WANG | 2012-04-18 | — | — | CN | claimed |
| CN-119497888-A | Hologram recording medium, method of manufacturing the same, and optical element including the same | 株式会社LG化学 | 2025-02-21 | — | — | CN | disclosed |
| CN-118162196-A | Heterogeneous catalyst for synthesizing benzyl phenylpropionate compound | 中国石油化工股份有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-118162196-A | Heterogeneous catalyst for synthesizing benzyl phenylpropionate compound | 中国石油化工股份有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-118162196-A | Heterogeneous catalyst for synthesizing benzyl phenylpropionate compound | 中国石油化工股份有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-109678718-B | Method for synthesizing phenylpropionic acid ester derivatives under catalysis of ionic liquid | 江西师范大学 | 2023-03-10 | — | — | CN | disclosed |
| CN-110903189-B | Synthesis method of chiral 2-aryl propionate | 大连大学 | 2022-06-21 | — | — | CN | disclosed |
| CN-107078352-B | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same | 三菱化学株式会社 | 2020-04-28 | — | — | CN | disclosed |
| CN-110903189-A | Synthesis method of chiral 2-aryl propionate | 大连大学 | 2020-03-24 | — | — | CN | disclosed |
| US-7538105-B2 | Anti-infective agents | ABBOTT LABORATORIES (US) | 2009-05-26 | — | — | US | disclosed |
| US-20080193413-A1 | Anti-Infective Agents | ABBOTT LABORATORIES (US) | 2008-08-14 | — | — | US | disclosed |
| US-7378414-B2 | Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1,1-dipropyl-2(1H)-naphthalenone | ABBOTT LABORATORIES (US) | 2008-05-27 | — | — | US | disclosed |
| CN-1236767-C | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORP (US) | 2006-01-18 | — | — | CN | disclosed |
| US-20050107364-A1 | Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1,1-dipropyl-2(1H)-naphthalenone | ABBVIE INC. | 2005-05-19 | — | — | US | disclosed |
| WO-2005019191-A2 | 1, 1-DIOXIDO-4H-1,2,4-BENZOTHIADIAZINE DERIVATE UND VERWANDTE VERBINDUNGEN ALS INHIBITOREN DER HCV POLYMERASE ZUR BEHANDLUNG VON HEPATITIS C | ABBOTT LABORATORIES (US) | 2005-03-03 | — | — | WO | disclosed |
| CN-1377269-A | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORP (US) | 2002-10-30 | — | — | CN | disclosed |
| CN-1299282-A | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORP (US) | 2001-06-13 | — | — | CN | disclosed |
| CN-1272841-A | Novel lactam metalloprotease inhibitors | DU PONT PHARM CO (US) | 2000-11-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080193413-A1 | Anti-Infective Agents | POLI, RPL5, POLRMT | ALDH1A1 2554/4885PPARG 813/4885PPARA 795/4885 |
| US-20050107364-A1 | Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1,1-dipropyl-2(1H)-naphthalenone | POLRMT, RNASE1, RNGTT | ALDH1A1 311/4885PPARG 1960/4885PPARA 1472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.